Drugs
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
347
NCT03931915
Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis
Phase: Phase 3
Role: Lead Sponsor
Start: May 8, 2019
Completion: Sep 28, 2020
NCT04118699
Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial
Phase: Phase 2
Role: Collaborator
Start: Dec 25, 2019
Completion: Jan 31, 2022
Loading map...